Antisense-MDM2 sensitizes LNCaP prostate cancer cells to androgen deprivation, radiation, and the combination in vivo.
about
Optimization of the balanced steady state free precession (bSSFP) pulse sequence for magnetic resonance imaging of the mouse prostate at 3TAn in-vivo investigation of the therapeutic effect of pulsed focused ultrasound on tumor growthMR-guided pulsed high intensity focused ultrasound enhancement of docetaxel combined with radiotherapy for prostate cancer treatment.Molecular fingerprinting of radiation resistant tumors: can we apprehend and rehabilitate the suspects?Immunohistochemical quantification of the vitamin B12 transport protein (TCII), cell surface receptor (TCII-R) and Ki-67 in human tumor xenografts.Adenovirus E2F1 overexpression sensitizes LNCaP and PC3 prostate tumor cells to radiation in vivo.PKA knockdown enhances cell killing in response to radiation and androgen deprivation.Tissue biomarkers for prostate cancer radiation therapy.MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner.Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor ActivityMDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo.Antisense MDM2 enhances E2F1-induced apoptosis and the combination sensitizes androgen-sensitive [corrected] and androgen-insensitive [corrected] prostate cancer cells to radiation.Predictive models in external beam radiotherapy for clinically localized prostate cancer.Signalling pathways in prostate carcinogenesis: potentials for molecular-targeted therapy.Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.Factors implicated in radiation therapy failure and radiosensitization of prostate cancer.Longitudinal anatomical and metabolic MRI characterization of orthotopic xenograft prostate tumors in nude mice.
P2860
Q28477693-015C8D65-7BF3-4794-BE62-E2F38FD5F254Q30367918-19B70EEE-1F26-415B-8027-5A785DF62C26Q30372703-7F558236-F64A-4BD0-AB3B-4F328545E75FQ33480331-2CFFF6DC-DF4E-4F33-B7DF-C5E273FFDDF5Q33702468-423BB195-0A8E-40A6-AB33-C6827CEB6376Q34986449-1914A7ED-7873-40F1-81F1-07737349F1C1Q36081726-7B875A34-AD75-4577-916A-6C65D64C3FDFQ36141341-CDDA8307-3E8D-43F0-8634-E96DDF7AA550Q36823926-D9860A53-452B-4061-9BB8-3820040349C9Q37066598-1B78F8FC-3117-4E44-BC63-3147DCB462B6Q37278373-867D3DB2-C75A-48C7-9C5E-0EEE3172E1C0Q37389886-85703ED5-D7DC-4459-BA9B-686DB9BE9A40Q37389921-2AC1D3BA-90DC-4F77-8B59-27FC2267D538Q37526758-8DC9C799-944A-4E52-955C-A2AB92849312Q37575815-BDF5EBAE-E5E1-4BDF-963D-EBFC45080172Q38180344-50DBB0FF-4AA8-47E2-A117-F89F2E265512Q38807901-4A1AF3DB-C45D-474A-AAD6-709301BC889CQ38985385-DF15F15D-CD59-407C-84E5-666176E3CFDD
P2860
Antisense-MDM2 sensitizes LNCaP prostate cancer cells to androgen deprivation, radiation, and the combination in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antisense-MDM2 sensitizes LNCa ...... , and the combination in vivo.
@en
Antisense-MDM2 sensitizes LNCa ...... , and the combination in vivo.
@nl
type
label
Antisense-MDM2 sensitizes LNCa ...... , and the combination in vivo.
@en
Antisense-MDM2 sensitizes LNCa ...... , and the combination in vivo.
@nl
prefLabel
Antisense-MDM2 sensitizes LNCa ...... , and the combination in vivo.
@en
Antisense-MDM2 sensitizes LNCa ...... , and the combination in vivo.
@nl
P2093
P2860
P1476
Antisense-MDM2 sensitizes LNCa ...... , and the combination in vivo.
@en
P2093
Alan Pollack
Harvey Hensley
Li-Yan Khor
M Elizabeth H Hammond
Paul Hachem
Radka Stoyanova
Sudhir Agrawal
Zhaomei Mu
P2860
P304
P356
10.1016/J.IJROBP.2007.03.047
P407
P577
2007-07-01T00:00:00Z